Zobrazeno 1 - 10
of 1 496
pro vyhledávání: '"M. Mehling"'
Publikováno v:
Archives of Orthopaedic and Trauma Surgery. 143:2789-2795
Autor:
Dumper, Michael
Publikováno v:
Bulletin (British Society for Middle Eastern Studies), 1988 Jan 01. 15(1/2), 150-150.
Externí odkaz:
https://www.jstor.org/stable/195270
Publikováno v:
Handchirurgie Scan. 11:135-144
Publikováno v:
Journal of Perinatology.
Autor:
Carl M. Mehling, Ronald J. Buta
Publikováno v:
Geological Curator. 11:307-321
An unmarked crate stored for many years in the American Museum of Natural History's Division of Paleontology was opened in 2005 and found to contain large slabs of small (one- to a few-centimetre-sized) fossil tetrapod footprints that were clearly ge
Autor:
Robert Vetrak, Milan Hric, Adriana Salatkova, Doreen Santora, Miriama Ovariova, Brian M. Mehling, Renata Mihalyova, Marine Manvelyan
Publikováno v:
Journal of Clinical Medicine Research
Background: Osteoarthritis (OA) is progressive degenerative damage to articular cartilage. Current therapeutic options are reduced to control the OA-associated symptoms, leaving the degenerative changes to progress until a joint replacement becomes m
Autor:
Michael Sauerbier, Michael Schlageter, J. Seegmüller, I. M. Mehling, Annika Arsalan-Werner, V Wingenbach
Publikováno v:
Archives of Orthopaedic and Trauma Surgery. 139:1161-1169
Headless compressions screws are the most implanted devices for scaphoid fractures and nonunions. For cases when screw osteosynthesis is not possible, a special locking plate for scaphoid reconstruction has been developed. The purpose of this study w
Autor:
M. Mehling
Publikováno v:
Carbon & Climate Law Review. 16:97-98
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e41767 (2012)
BackgroundVaranidae is a clade of tiny (600 mm PCL) lizards first appearing in the Cretaceous. True monitor lizards (Varanus) are known from diagnostic remains beginning in the early Miocene (Varanus rusingensis), although extremely fragmentary remai
Externí odkaz:
https://doaj.org/article/92a1da315327432ea9641ffd8b3217ab
Autor:
Maria Rasenack, Till Sprenger, S. Von Felten, Michaela Andelova, M. Mehling, Yvonne Naegelin, Tobias Derfuss, Michael Amann, B. Fischer-Barnicol, Ludwig Kappos
Publikováno v:
Multiple Sclerosis and Related Disorders. 25:14-20
BACKGROUND There is limited evidence about the optimal length of washout when switching from natalizumab to fingolimod. OBJECTIVE To study if a washout period of 4 weeks is associated with less disease activity compared to 8 weeks. METHODS 25 patient